Showing results (1-10 of 1,886) with videos related to
Sort By:
Pageof 189
Archives of Pathology & Laboratory Medicine|January 11, 2000
Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemiaJ Faber, H Kantarjian, M W Roberts, et al.British Journal of Haematology|September 1, 2001
Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndromeS Verstovsek, H Kantarjian, A Aguayo, et al.Cancer|March 4, 2000
ATM gene deletion in patients with adult acute lymphoblastic leukemiaM A Haidar, H Kantarjian, T Manshouri, et al.Cancer Research|October 27, 1998
Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemiaP Starostik, T Manshouri, S O'Brien, et al.Leukemia Research|September 4, 1999
The prognostic significance of 13q14 deletions in chronic lymphocytic leukemiaP Starostik, S O'Brien, C Y Chung, et al.Cancer|March 16, 2000
Deletions in the 13q14 locus in adult lymphoblastic leukemia: rate of incidence and relevanceC Y Chung, H Kantarjian, M Haidar, et al.Leukemia Research|April 27, 2000
Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemiaF Ravandi-Kashani, S O'Brien, T Manshouri, et al.Leukemia Research|February 5, 1999
Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemiaM Albitar, T Manshouri, H Kantarjian, et al.American Journal of Clinical Pathology|December 10, 1999
De novo CD5+ Burkitt lymphoma/leukemiaC W Lin, S O'Brien, J Faber, et al.Leukemia|August 2, 2001
Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromeS Verstovsek, H Kantarjian, E Estey, et al.Pageof 189